News

Coffee consumption is a daily ritual for many. It's a comforting start to the day and, for some, a midday and evening pick-me-up. But how much is too much? Understanding coffee consumption is crucial because it can influence your health significantly. Too much caffeine can lead to health issues; knowing how much coffee is healthy for you helps you enjoy the benefits without the risks.

Below, learn more about the pros and cons of coffee consumption, how much caffeine is in a cup of coffee, and how much coffee is healthy for you.

Confused about probiotics and prebiotics? Let’s unravel the mysteries of how prebiotic and probiotic foods promote a balanced gut and what role that plays in your overall wellness.

Remember, even researchers are just beginning to understand the complexity of digestive health: how each organ functions and what the microorganisms within them do to keep the whole digestive system in working order. Before you alter your diet and lifestyle to consume more probiotics and prebiotics, consult with your primary care physician for personal guidance on healthy eating for your gut.

If you’ve recently noticed prebiotic and probiotic sodas popping up on the shelves of your local grocery store, you’re not alone. TikTok has made these drinks — which claim to improve your gut microbiome, lower cholesterol, aid in weight loss, moderate blood sugar and enhance skin complexion — the newest “it” product to try.

Every day for the next five years, 10,000 Baby Boomers will turn 65, and by 2030, 18 percent of the U.S. population will be age 65 or older according to the Pew Research Center. While old age certainly doesn’t begin at 65, it’s not unreasonable to think as we age, we may need help from loved ones. Millions of Americans already act as caregivers each year.

For neurologists working with patients with Alzheimer’s disease, the road to actual treatment options has been long and paved with setbacks.

But that is changing for some patients. The Food and Drug Administration recently granted full approval to Leqembi® (lecanemab), the first disease-modifying treatment fully approved for patients in the early stages of Alzheimer’s disease. The development of this new drug offers hope to patients and may have lasting impacts on how physicians approach treatment.